While searching for mutations with a next generation sequencing (NGS) approach with MPN associated genes (ABL1, ASXL1, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1, ZRSR2), we discovered that almost 50% of patients with idiopathic-SVT display somatic mutations. This evidence concerns the gene CALR and myeloproliferative neoplasm.